Byung-Gi Lee
Fortuna: 11 M $ al 30/06/2026
Fortuna: 11 M $ al 30/06/2026
Byung-Gi Lee is currently the Chairman & Chief Executive Officer at Sinsin Pharmaceutical Co., Ltd. since 2026 and a Professor at Myongji University.
The education history includes a doctorate from the University of Michigan and a graduate degree from Seoul National University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/02/2026 | 3.998.760 ( 26,36 % ) | 11 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SINSIN PHARMACEUTICAL CO., LTD | Director Ejecutivo | 01/07/2016 |
Myongji University
Myongji University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myongji University
Myongji University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinsin Pharmaceutical Co., Ltd.
Sinsin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.